427 Views

Annual Scientific Meeting

Session: Bonus Session D: Onco-Gastroenterology: What You Need to Know About GI Toxicity of Novel Cancer Therapies and Genetic Testing

GI Toxicity of Emerging Cancer Therapies: Targeted Therapy, Checkpoint Inhibitors, and Beyond

Monday, October 24, 2022

ON DEMAND (Must purchase Bonus Sessions to have access)

Location: ON-DEMAND

Speaker(s)

Recognize the spectrum of GI toxicity of molecular-targeted agents, checkpoint inhibitors, and emerging cancer treatment modalities, and formulate strategies for management.